119 related articles for article (PubMed ID: 25511093)
1. [Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].
Yang L; Tian X; Guo R; Liu H; Qi F; Ye J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):740-3. PubMed ID: 25511093
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome.
Xu S; Tang L; Mi Y; Jiang J; Zhu M; Chen B; Wang B; Li T; Xu C; Wang J; Lu X; Ge W; Wang L; Huang J
Clin Invest Med; 2013 Dec; 36(6):E282-9. PubMed ID: 24309224
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Extracellular Matrix Metalloproteinase Inducer in Peripheral Blood and Serum MMPs in patients with Acute Coronary Syndrome.
Wang W
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):97-104. PubMed ID: 37114301
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
5. [Urokinase-type plasminogen activator and its inhibitor type 1 in the diagnosis of evolving complications in coronary heart disease].
Pal'tseva EM; Rodina AV; Andreev DA; Popova ON; Gusev DE; Severin SE; Syrkin AL
Klin Lab Diagn; 2010 Jun; (6):51-5. PubMed ID: 20734863
[TBL] [Abstract][Full Text] [Related]
6. [Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome].
Wang B; Xu SS; Jiang JJ; Lu XB; Xue YS; Wang JC; Mi YF; Zhu M; Ge WL; Tang LJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):416-20. PubMed ID: 22883094
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.
Hu JH; Du L; Chu T; Otsuka G; Dronadula N; Jaffe M; Gill SE; Parks WC; Dichek DA
Circulation; 2010 Apr; 121(14):1637-44. PubMed ID: 20351234
[TBL] [Abstract][Full Text] [Related]
9. Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography.
Pflederer T; Marwan M; Schepis T; Ropers D; Seltmann M; Muschiol G; Daniel WG; Achenbach S
Atherosclerosis; 2010 Aug; 211(2):437-44. PubMed ID: 20189568
[TBL] [Abstract][Full Text] [Related]
10. CT attenuation features of individual calcified coronary plaque: differences among asymptomatic, stable angina pectoris, and acute coronary syndrome groups.
Huang YL; Lin HS; Wu CC; Wu FZ; Yeh C; Chiou KR; Mar GY; Wu MT
PLoS One; 2015; 10(6):e0131254. PubMed ID: 26106881
[TBL] [Abstract][Full Text] [Related]
11. The different association of epicardial fat with coronary plaque in patients with acute coronary syndrome and patients with stable angina pectoris: analysis using integrated backscatter intravascular ultrasound.
Harada K; Harada K; Uetani T; Kataoka T; Takeshita M; Kunimura A; Takayama Y; Shinoda N; Kato B; Kato M; Marui N; Ishii H; Matsubara T; Amano T; Murohara T
Atherosclerosis; 2014 Oct; 236(2):301-6. PubMed ID: 25117765
[TBL] [Abstract][Full Text] [Related]
12. Risk factor profiling and study of atherosclerotic coronary plaque burden and morphology with coronary computed tomography angiography in coronary artery disease among young Indians.
Chaudhary R; Chauhan A; Singhal M; Bagga S
Int J Cardiol; 2017 Aug; 240():452-457. PubMed ID: 28477962
[TBL] [Abstract][Full Text] [Related]
13. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
[TBL] [Abstract][Full Text] [Related]
14. [Classification and functional study of peripheral blood dendritic cells in patients with coronary artery disease with different atherosclerotic plaques].
Tu XW; Li ZL; Liu YF; Wei XL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1195-8. PubMed ID: 19726360
[TBL] [Abstract][Full Text] [Related]
15. Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis.
Kampf S; Micko A; Stojkovic S; Nackenhorst M; Demyanets S; Eilenberg WH; Krenn C; Wojta J; Neumayer C
Eur J Vasc Endovasc Surg; 2023 Apr; 65(4):474-483. PubMed ID: 36529365
[TBL] [Abstract][Full Text] [Related]
16. Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.
Kienast J; Padró T; Steins M; Li CX; Schmid KW; Hammel D; Scheld HH; van de Loo JC
Thromb Haemost; 1998 Mar; 79(3):579-86. PubMed ID: 9531045
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel inhibitor against urokinase-type plasminogen activator, a potential enzyme with a role in atherosclerotic plaque instability.
Ganguly R; Mylliemngap BJ; Bhattacharjee A
J Biomol Struct Dyn; 2023 May; 41(8):3485-3495. PubMed ID: 35362361
[TBL] [Abstract][Full Text] [Related]
18. Increased Urokinase-Type Plasminogen Activator Receptor Expression on Circulating Monocytes Is Correlated with Clinical Instability and Long-Term Adverse Cardiac Events in Patients with Coronary Artery Disease.
Zhang Y; Chen W; Chen LF; Wang X; Hsu J; Fang LG; Fang Q
Cardiology; 2016; 135(2):98-107. PubMed ID: 27299738
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome].
Wu XL; Yu L; Long D; Yang JH; Zhang YC; Geng F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):478-81. PubMed ID: 21878172
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Extracellular Matrix Metalloproteinase Inducer Polymorphisms and Coronary Heart Disease: A Potential Way to Predict Disease.
Weng Y; Chen T; Ren J; Lu D; Liu X; Lin S; Xu C; Lou J; Chen X; Tang L
DNA Cell Biol; 2020 Feb; 39(2):244-254. PubMed ID: 31928425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
